Left ventricular dyssynchrony and 2D and 3D global longitudinal strain for differentiating physiological and

Julien Ternacle1, Camille Bremont1, Thomas d'Humieres1

  • 1AP-HP, Henri Mondor University Hospital, Cardiovascular department and Inserm U955, 51, avenue de Lattre-de-Tassigny, 94100 Créteil, France.

Insights

Diagnosing hypertrophic cardiomyopathy (HCM) in athletes is difficult. Left ventricular (LV) dyssynchrony and 2D global longitudinal strain (GLS) can differentiate HCM patients from athletes with LV hypertrophy.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Medical Imaging

Background:

  • Differentiating hypertrophic cardiomyopathy (HCM) from physiological left ventricular hypertrophy (LVH) in athletes presents diagnostic challenges.
  • Athletes often exhibit increased left ventricular (LV) mass due to training, mimicking HCM.
  • Accurate differentiation is crucial for appropriate management and preventing adverse outcomes.

Purpose of the Study:

  • To identify parameters distinguishing HCM patients from athletes with moderate LVH (13-15mm).
  • To evaluate the diagnostic accuracy of echocardiographic strain parameters, including LV dyssynchrony and global longitudinal strain (GLS).

Main Methods:

  • Retrospective analysis of 100 men: 50 elite rugby players (25 with moderate LVH, 25 without), 25 HCM patients with moderate LVH, and 25 controls.
  • Assessment of LV dyssynchrony using standard deviation of time to peak 2D longitudinal strain.
  • Computation of 2D and 3D global strain components using speckle tracking echocardiography.

Main Results:

  • LV volumes and dyssynchrony were significantly greater in athletes with moderate LVH compared to controls.
  • LV dyssynchrony demonstrated high accuracy (AUC=0.92) in differentiating HCM from athletes.
  • Combining LV dyssynchrony with 2D GLS improved diagnostic accuracy, with preserved 2D GLS (>18%) and no LV dyssynchrony (>48ms) effectively excluding HCM.

Conclusions:

  • Left ventricular (LV) dyssynchrony, assessed by speckle tracking, is a key differentiator between HCM and athlete's heart.
  • The combination of LV dyssynchrony and 2D global longitudinal strain (GLS) provides a robust method for distinguishing HCM in athletes.
  • These parameters aid in excluding HCM in athletes presenting with LV hypertrophy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373